Emergent BioSolutions, Inc. is launching Emergard, a ruggedized, military-grade auto-injector device designed for intramuscular self-injection of antidotes and other emergency medical countermeasures. Emergent plans to pursue FDA approval of the device in the U.S. The company has received preliminary interest for Emergard from countries outside the U.S. and anticipates making its first deliveries in limited quantities in 4Q15. Emergard is designed to be transported, stored, and operated in a mil...